Cargando…

Assessment of Screening Approach in Early and Differential Alzheimer’s Disease Diagnosis

Background: Alzheimer’s disease (AD) is the leading cause of dementia in the elderly population. Currently, diagnosis is based on invasive and expensive techniques, so there is a growing need to look for other possible tests, as well as carry out clinical validation. Studies from the literature show...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ferré-González, Laura, Peña-Bautista, Carmen, Álvarez-Sánchez, Lourdes, Ferrer-Cairols, Inés, Baquero, Miguel, Cháfer-Pericás, Consuelo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8614769/ https://www.ncbi.nlm.nih.gov/pubmed/34829533 http://dx.doi.org/10.3390/antiox10111662

Ejemplares similares

Discordant Amyloid Status Diagnosis in Alzheimer’s Disease
por: García-Vallés, Lorena, et al.
Publicado: (2022)

Assessment of Lipid Peroxidation in Alzheimer’s Disease Differential Diagnosis and Prognosis
por: Ferré-González, Laura, et al.
Publicado: (2022)

Early Alzheimer’s Disease Screening Approach Using Plasma Biomarkers
por: Álvarez-Sánchez, Lourdes, et al.
Publicado: (2023)

Plasma Lipidomics Approach in Early and Specific Alzheimer’s Disease Diagnosis
por: Peña-Bautista, Carmen, et al.
Publicado: (2022)

Epigenomics and Lipidomics Integration in Alzheimer Disease: Pathways Involved in Early Stages
por: Peña-Bautista, Carmen, et al.
Publicado: (2021)

Assessment of Plasma and Cerebrospinal Fluid Biomarkers in Different Stages of Alzheimer’s Disease and Frontotemporal Dementia
por: Álvarez-Sánchez, Lourdes, et al.
Publicado: (2023)

Clinical Utility of Plasma Lipid Peroxidation Biomarkers in Alzheimer’s Disease Differential Diagnosis
por: Peña-Bautista, Carmen, et al.
Publicado: (2020)

Lipids as Early and Minimally Invasive Biomarkers for Alzheimer’s Disease
por: Casas-Fernández, Esther, et al.
Publicado: (2022)

Recent Evidence in Epigenomics and Proteomics Biomarkers for Early and Minimally Invasive Diagnosis of Alzheimer’s and Parkinson’s Diseases
por: Mayo, Sonia, et al.
Publicado: (2021)

Lipid Peroxidation Assessment in Preclinical Alzheimer Disease Diagnosis
por: Peña-Bautista, Carmen, et al.
Publicado: (2021)

Early neurotransmission impairment in non-invasive Alzheimer Disease detection
por: Peña-Bautista, Carmen, et al.
Publicado: (2020)

Plasma microRNAs as potential biomarkers in early Alzheimer disease expression
por: Peña-Bautista, Carmen, et al.
Publicado: (2022)

Oxidative Damage of DNA as Early Marker of Alzheimer’s Disease
por: Peña-Bautista, Carmen, et al.
Publicado: (2019)

Isoprostanoids Levels in Cerebrospinal Fluid Do Not Reflect Alzheimer’s Disease
por: Peña-Bautista, Carmen, et al.
Publicado: (2020)

New screening approach for Alzheimer’s disease risk assessment from urine lipid peroxidation compounds
por: Peña-Bautista, Carmen, et al.
Publicado: (2019)

Misfolded alpha-synuclein detection by RT-QuIC in dementia with lewy bodies: a systematic review and meta-analysis
por: Peña-Bautista, Carmen, et al.
Publicado: (2023)

Angiotensin II Receptor Blockers Reduce Tau/Aß42 Ratio: A Cerebrospinal Fluid Biomarkers’ Case-Control Study
por: García-Lluch, Gemma, et al.
Publicado: (2023)

Lipid Peroxidation in Neurodegeneration
por: Cháfer-Pericás, Consuelo
Publicado: (2021)

CRIDECO Anticholinergic Load Scale: An Updated Anticholinergic Burden Scale. Comparison with the ACB Scale in Spanish Individuals with Subjective Memory Complaints
por: Ramos, Hernán, et al.
Publicado: (2022)

Mass spectrometric detection of biomarkers for early assessment of intraamniotic fluid infection
por: Cháfer-Pericás, Consuelo, et al.
Publicado: (2015)

Oxygen Supplementation to Stabilize Preterm Infants in the Fetal to Neonatal Transition: No Satisfactory Answer
por: Torres-Cuevas, Isabel, et al.
Publicado: (2016)

Oxygen and oxidative stress in the perinatal period
por: Torres-Cuevas, Isabel, et al.
Publicado: (2017)

Gold Nanoparticle-Assisted Virus Formation by Means of the Delivery of an Oncolytic Adenovirus Genome
por: Sendra, Luis, et al.
Publicado: (2020)

Trajectories of stress biomarkers and anxious-depressive symptoms from pregnancy to postpartum period in women with a trauma history
por: Ghosn, Farah, et al.
Publicado: (2019)

Hadroproduccion y desintegracion de particulas con los quarks c O b en el experimento WA-71 del CERN
por: Salt Cairols, Jose
Publicado: (2011)

Cerebrospinal Fluid Biomarkers for Early and Differential Alzheimer’s Disease Diagnosis
por: Bjerke, Maria, et al.
Publicado: (2018)

Awareness of Diagnosis in Persons with Early-Stage Alzheimer’s Disease: An Observational Study in Spain
por: Villarejo-Galende, Alberto, et al.
Publicado: (2022)

Exclusiones y resistencias de niños inmigrantes en escuelas de Quito /
por: Sánchez Bautista, Consuelo
Publicado: (2013)

Can stress predict delivery date?: Role of chronic and acute stress to the threatened preterm labor as predictors of delivery date
por: Lorenzo, J. Buesa, et al.
Publicado: (2021)

“Hypothyroidism screening during first trimester of pregnancy”
por: Castillo Lara, María, et al.
Publicado: (2017)

Biomarkers in Alzheimer’s disease: role in early and differential diagnosis and recognition of atypical variants
por: Dubois, Bruno, et al.
Publicado: (2023)

Evaluation of molecular diagnosis in fungal keratitis. Ten years of experience
por: Ferrer, Consuelo, et al.
Publicado: (2011)

Non-invasive screening for early Alzheimer’s disease diagnosis by a sensitively immunomagnetic biosensor
por: Li, Shan-Shan, et al.
Publicado: (2016)

Diagnosis of Alzheimer’s disease with Electroencephalography in a differential framework
por: Houmani, Nesma, et al.
Publicado: (2018)

Routine lumbar puncture for the early diagnosis of Alzheimer's disease. Is it safe?
por: Menéndez-González, Manuel
Publicado: (2014)

The relevance of music therapy in paediatric and adolescent cancer patients: a scoping review
por: Rodríguez-Rodríguez, Román-Carlos, et al.
Publicado: (2022)

Plasma Lipocalin 2 in Alzheimer’s disease: potential utility in the differential diagnosis and relationship with other biomarkers
por: Hermann, Peter, et al.
Publicado: (2022)

Protein Markers for the Differential Diagnosis of Vascular Dementia and Alzheimer's Disease
por: Simonsen, A. H., et al.
Publicado: (2012)

Differences in breast cancer risk after benign breast disease by type of screening diagnosis
por: Louro, Javier, et al.
Publicado: (2020)

The Progress of Label-Free Optical Imaging in Alzheimer’s Disease Screening and Diagnosis
por: Liu, Kai, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_eog20mjncrer65g3cr7k5bp47g